PECAM1 and Thrombocytopenia: LA, however, dramatically increased PECAM-1/CD31 expression in the alveolar capillaries and pulmonary vascular thrombi (red squares, oval, Figure 6J), with the mice developing thrombocytopenia and an elevated activated clotting time (Figures 6K–6L).